Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 40 out of 492
4918 citations found

Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis

Suvieri, C;Volpi, C;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler’s Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE

Moriguchi, K;Nakamura, Y;Park, AM;Sato, F;Kuwahara, M;Khadka, S;Omura, S;Ahmad, I;Kusunoki, S;Tsunoda, I;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • 4.2. Induction and Evaluation of EAE

    We induced EAE by subcutaneous (s.c.) sensitization with 100 nmol/mouse of modified PLP139–151 peptide (VSLGKWLGHPDKF, United BioSystems, Herndon, VA, USA) in SJL/J mice, MOG92–106 peptide (DEGGYTCFFRDHSYQ, United BioSystems) in SJL/J mice or A.SW mice, or MOG35–55 (MEVGWYRSPFSRVVHLYRNGK, United BioSystems) peptide in C57BL/6 mice, in which myelin peptides were emulsified in CFA composed of incomplete Freund’s adjuvant (BD, Franklin Lakes, NJ, USA] and Mycobacterium tuberculosis H37 Ra (BD)…. To induce chronic MOG35–55-induced EAE, we injected C57BL/6 mice twice with MOG35–55 s.c. on days 0 and 19 and 300 ng of pertussis toxin (List Biological Laboratories, Campbell, CA, USA) i.p. on days 0 and 2 [63]. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Stat1 is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation

Imitola, J;Hollingsworth, EW;Watanabe, F;Olah, M;Elyaman, W;Starossom, S;Kivisäkk, P;Khoury, SJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • EAE induction

    All experiments were conducted under the approval of the Harvard Medical School Animal Care committee and the Animal Care. SJL/J mice were immunized subcutaneously in two sites (left and right flank) with 150 μg of PLP139-151 (New England Peptide LLC., Gardner, MA) emulsified in complete Freund’s adjuvant (CFA, Sigma Aldrich, Saint Louis, MO) containing 200 μg Mycobacterium Tuberculosis (Difco Laboratories, Detroit, MI). Mice received 200 ng pertussis toxin (PT, List Biological Laboratories Inc., Campbell, CA) in 0.2 ml PBS (Lonza, Walkersville, MD) intraperitoneally (ip) at the time of immunization and 48 h later. Control mice were immunized with CFA followed by PT (12). The mice were sacrificed at different time points. For MOG 35–55 (M-E-V-G-W-Y-R-S-P-F-S-R-O-V-H-L-Y-R-N-G-K) corresponding to mouse sequence is synthesized by QCB Inc. Division of BioSource International (Hopkinton, MA), and purified to > 99% by HPLC. Mice are immunized subcutaneously in the flanks with 150–200 μg of MOG peptide in 0.1 ml PBS and 0.1 ml CFA containing 0.4 mg Mycobacterium Tuberculosis (H37Ra, Difco, Detroit, Michigan) and injected i.p. with 200 ng Pertussis toxin (List Laboratories, Campbell, California) on the day of immunization and 2 days later. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Multi-Compartmental Analysis of the Murine Pulmonary Immune Response by Spectral Flow Cytometry

Chang, MY;Brune, JE;Black, M;Altemeier, WA;Frevert, CW;

Product: LPS from Escherichia coli O111:B4

  • Lipopolysaccharide, Bleomycin, House Dust Mite Administration

    Lipopolysaccharide (LPS, Escherichia coli O111: B4, List Biological Laboratories, Campbell, CA, USA) was administered by oropharyngeal aspiration under isoflurane anesthesia at a dose of 2.0 mg/kg of mouse body weight in 50μL of PBS. …

    Product #201 – LPS from Escherichia coli O111:B4

A regulatory circuit controlled by extranuclear and nuclear retinoic acid receptor α determines T cell activation and function

Larange, A;Takazawa, I;Kakugawa, K;Thiault, N;Ngoi, S;Olive, ME;Iwaya, H;Seguin, L;Vicente-Suarez, I;Becart, S;Verstichel, G;Balancio, A;Altman, A;Chang, JT;Taniuchi, I;Lillemeier, B;Kronenberg, M;Myers, SA;Cheroutre, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

“Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model”

Kapil, P;Wang, Y;Zimmerman, L;Gaykema, M;Merkel, TJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease

Garretti, F;Monahan, C;Sloan, N;Bergen, J;Shahriar, S;Kim, SW;Sette, A;Cutforth, T;Kanter, E;Agalliu, D;Sulzer, D;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Immunizations

    8- to 12-week-old male and female mice were immunized subcutaneously with a 100 μl emulsion of 100 μg α-syn32-46 peptide (A&A peptides; San Diego, CA) dissolved in PBS with Complete Freund Adjuvant (CFA) containing 200 μg M. tuberculosis H37Ra (BD Difco Adjuvant, Fisher Scientific, Cat #DF0638-60-7; Waltham, MA). The day of immunization was designated as day 0. Mice received a boost with the same immunization dose two weeks later. Mice received intravenous injections of 400 ng of B. pertussis toxin (List Biological Laboratories, Cat #181; Campbell, CA) 14- and 16-days post-initial immunization (day 0 and 2 post boost). …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers

Gress, C;Vogel-Claussen, J;Badorrek, P;Müller, M;Hohl, K;Konietzke, M;Litzenburger, T;Seibold, W;Gupta, A;Hohlfeld, JM;

Product: LIST™ HPT™ from Escherichia coli O113

  • Methods
    In a monocentric, randomized, double-blind, placebo-controlled, parallel-group, phase I trial, 57 healthy, smoking subjects were treated for 28 days with either oral BI 1026706 100 mg bid or placebo. At day 21, turbo-inversion recovery magnitude magnetic resonance imaging (TIRM MRI) was performed. On the last day of treatment, pre-challenge bronchoalveolar lavage fluid (BAL) and biopsies were sampled, followed by segmental LPS challenge (40 endotoxin units/kg body weight) and saline control instillation in different lung lobes. Twenty-four hours later, TIRM MRI was performed, then BAL and biopsies were collected from the challenged segments. In BAL samples, cells were differentiated for neutrophil numbers as the primary endpoint. Other endpoints included assessment of safety, biomarkers in BAL (e.g. interleukin-8 [IL-8], albumin and total protein), B1R expression in lung biopsies and TIRM score by MRI as a measure for the extent of pulmonary oedema.

    … Next, Lipopolysaccharide (Endotoxin from E. coli Type O113 provided by National Institutes of Health Clinical Center, Bethesda, Maryland, USA and produced by List Biological Laboratories Inc., Campbell, California, USA) at a dose of 40 endotoxin units (E.U.)/kg …

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113

Direct and Indirect Nociceptive Input from the Trigeminal Dorsal Horn to Pain-Modulating Neurons in the Rostral Ventromedial Medulla

De Preter, CC;Heinricher, MM;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Proteolipid Protein-Induced Mouse Model of Multiple Sclerosis Requires B Cell-Mediated Antigen Presentation

Wilhelm, CR;Upadhye, MA;Eschbacher, KL;Karandikar, NJ;Boyden, AW;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer